Cargando…
Adjuvant Chemotherapy Might Be Recommended to Patients With Positive Margin After Gastrectomy: A 20-Year Retrospective Analysis in a Single Center
BACKGROUND: Margin positivity after gastric cancer resection is associated with poorer outcomes. However, the prognostic factors and the choice of postoperative adjuvant treatment of patients with positive margin (PM) after gastrectomy are still being debated. METHODS: A single-center, retrospective...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847385/ https://www.ncbi.nlm.nih.gov/pubmed/35186712 http://dx.doi.org/10.3389/fonc.2021.794032 |
_version_ | 1784652037644877824 |
---|---|
author | Zhang, Xiaojie Zhao, Lulu Niu, Penghui Wang, Tongbo Wang, Wanqing Sun, Chongyuan Li, Zefeng Chen, Yingtai Zhao, Dongbing |
author_facet | Zhang, Xiaojie Zhao, Lulu Niu, Penghui Wang, Tongbo Wang, Wanqing Sun, Chongyuan Li, Zefeng Chen, Yingtai Zhao, Dongbing |
author_sort | Zhang, Xiaojie |
collection | PubMed |
description | BACKGROUND: Margin positivity after gastric cancer resection is associated with poorer outcomes. However, the prognostic factors and the choice of postoperative adjuvant treatment of patients with positive margin (PM) after gastrectomy are still being debated. METHODS: A single-center, retrospective analysis was conducted for patients with PM after gastrectomy from the China National Cancer Center Gastric Cancer Database (NCCGCDB) from 1998 to 2018. Univariate and multivariate Cox regression analyses were performed to identify prognostic factors of overall survival (OS) and recurrence-free survival (RFS). RESULTS: A total of 449 patients were included in the study, including 192 (42.8%) in the proximal PM group (PPM), 205 (45.7%) in the distal PM group (DPM), and 52 (11.6%) in the bilateral PM group (BPM). The 3- and 5-year OS rates for the PM patients investigated were 47.5% and 39.3%, respectively, and the 3- and 5-year RFS rates were 60.0% and 53.6%, respectively. Multivariate Cox regression analysis proved total gastrectomy (hazard ratio (HR): 1.783, 95%CI: 1.133–2.805, p = 0.012), pT4 (HR: 5.264, 95%CI: 1.493–18.565, p = 0.01), pN2 (HR: 2.263, 95%CI: 1.164–4.397, p = 0.016), pN3 (HR: 2.327, 95%CI: 1.233–4.393, p = 0.009), and combined resection (HR: 1.952, 95%CI: 1.256–3.034, p = 0.003) to be independent risk factors of OS, and pT3 (HR: 9.257, 95%CI: 1.152–74.386, p = 0.036) and pT4 (HR: 11.361, 95%CI: 1.469–87.847, p = 0.020) to be independent risk factors for RFS. Adjuvant chemotherapy prolonged OS in the PPM group (p = 0.032) and prolonged RFS in the PPM group (p < 0.001) and the DPM group (p = 0.035) compared with surgery alone. CONCLUSIONS: Advanced pathologic stage was associated with poor prognosis, and postoperative adjuvant chemotherapy might be recommended in PM patients after gastrectomy. Still, further prospective trials are warranted to verify and support our conclusions. |
format | Online Article Text |
id | pubmed-8847385 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88473852022-02-17 Adjuvant Chemotherapy Might Be Recommended to Patients With Positive Margin After Gastrectomy: A 20-Year Retrospective Analysis in a Single Center Zhang, Xiaojie Zhao, Lulu Niu, Penghui Wang, Tongbo Wang, Wanqing Sun, Chongyuan Li, Zefeng Chen, Yingtai Zhao, Dongbing Front Oncol Oncology BACKGROUND: Margin positivity after gastric cancer resection is associated with poorer outcomes. However, the prognostic factors and the choice of postoperative adjuvant treatment of patients with positive margin (PM) after gastrectomy are still being debated. METHODS: A single-center, retrospective analysis was conducted for patients with PM after gastrectomy from the China National Cancer Center Gastric Cancer Database (NCCGCDB) from 1998 to 2018. Univariate and multivariate Cox regression analyses were performed to identify prognostic factors of overall survival (OS) and recurrence-free survival (RFS). RESULTS: A total of 449 patients were included in the study, including 192 (42.8%) in the proximal PM group (PPM), 205 (45.7%) in the distal PM group (DPM), and 52 (11.6%) in the bilateral PM group (BPM). The 3- and 5-year OS rates for the PM patients investigated were 47.5% and 39.3%, respectively, and the 3- and 5-year RFS rates were 60.0% and 53.6%, respectively. Multivariate Cox regression analysis proved total gastrectomy (hazard ratio (HR): 1.783, 95%CI: 1.133–2.805, p = 0.012), pT4 (HR: 5.264, 95%CI: 1.493–18.565, p = 0.01), pN2 (HR: 2.263, 95%CI: 1.164–4.397, p = 0.016), pN3 (HR: 2.327, 95%CI: 1.233–4.393, p = 0.009), and combined resection (HR: 1.952, 95%CI: 1.256–3.034, p = 0.003) to be independent risk factors of OS, and pT3 (HR: 9.257, 95%CI: 1.152–74.386, p = 0.036) and pT4 (HR: 11.361, 95%CI: 1.469–87.847, p = 0.020) to be independent risk factors for RFS. Adjuvant chemotherapy prolonged OS in the PPM group (p = 0.032) and prolonged RFS in the PPM group (p < 0.001) and the DPM group (p = 0.035) compared with surgery alone. CONCLUSIONS: Advanced pathologic stage was associated with poor prognosis, and postoperative adjuvant chemotherapy might be recommended in PM patients after gastrectomy. Still, further prospective trials are warranted to verify and support our conclusions. Frontiers Media S.A. 2022-02-02 /pmc/articles/PMC8847385/ /pubmed/35186712 http://dx.doi.org/10.3389/fonc.2021.794032 Text en Copyright © 2022 Zhang, Zhao, Niu, Wang, Wang, Sun, Li, Chen and Zhao https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Zhang, Xiaojie Zhao, Lulu Niu, Penghui Wang, Tongbo Wang, Wanqing Sun, Chongyuan Li, Zefeng Chen, Yingtai Zhao, Dongbing Adjuvant Chemotherapy Might Be Recommended to Patients With Positive Margin After Gastrectomy: A 20-Year Retrospective Analysis in a Single Center |
title | Adjuvant Chemotherapy Might Be Recommended to Patients With Positive Margin After Gastrectomy: A 20-Year Retrospective Analysis in a Single Center |
title_full | Adjuvant Chemotherapy Might Be Recommended to Patients With Positive Margin After Gastrectomy: A 20-Year Retrospective Analysis in a Single Center |
title_fullStr | Adjuvant Chemotherapy Might Be Recommended to Patients With Positive Margin After Gastrectomy: A 20-Year Retrospective Analysis in a Single Center |
title_full_unstemmed | Adjuvant Chemotherapy Might Be Recommended to Patients With Positive Margin After Gastrectomy: A 20-Year Retrospective Analysis in a Single Center |
title_short | Adjuvant Chemotherapy Might Be Recommended to Patients With Positive Margin After Gastrectomy: A 20-Year Retrospective Analysis in a Single Center |
title_sort | adjuvant chemotherapy might be recommended to patients with positive margin after gastrectomy: a 20-year retrospective analysis in a single center |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847385/ https://www.ncbi.nlm.nih.gov/pubmed/35186712 http://dx.doi.org/10.3389/fonc.2021.794032 |
work_keys_str_mv | AT zhangxiaojie adjuvantchemotherapymightberecommendedtopatientswithpositivemarginaftergastrectomya20yearretrospectiveanalysisinasinglecenter AT zhaolulu adjuvantchemotherapymightberecommendedtopatientswithpositivemarginaftergastrectomya20yearretrospectiveanalysisinasinglecenter AT niupenghui adjuvantchemotherapymightberecommendedtopatientswithpositivemarginaftergastrectomya20yearretrospectiveanalysisinasinglecenter AT wangtongbo adjuvantchemotherapymightberecommendedtopatientswithpositivemarginaftergastrectomya20yearretrospectiveanalysisinasinglecenter AT wangwanqing adjuvantchemotherapymightberecommendedtopatientswithpositivemarginaftergastrectomya20yearretrospectiveanalysisinasinglecenter AT sunchongyuan adjuvantchemotherapymightberecommendedtopatientswithpositivemarginaftergastrectomya20yearretrospectiveanalysisinasinglecenter AT lizefeng adjuvantchemotherapymightberecommendedtopatientswithpositivemarginaftergastrectomya20yearretrospectiveanalysisinasinglecenter AT chenyingtai adjuvantchemotherapymightberecommendedtopatientswithpositivemarginaftergastrectomya20yearretrospectiveanalysisinasinglecenter AT zhaodongbing adjuvantchemotherapymightberecommendedtopatientswithpositivemarginaftergastrectomya20yearretrospectiveanalysisinasinglecenter |